A randomized, parallel-group, double-blind, placebo-controlled, multi-center study of eculizumab for the prevention of delayed graft function after kidney transplantation in adult subjects at increased risk of delayed graft function
Administered By
Awarded By
Contributors
- Sudan, Debra L Principal Investigator
Start/End
- August 1, 2014 - September 8, 2016